Result Summary for S3A40095
| Protocol ID: | S3A40095 |
| Clinical Study ID: | S3A40095 (517/110) |
| Official Title: | An assessment of the effect of schedule and maintenance on the antiemetic efficacy and safety of ondansetron combined with dexamethasone as acute and maintenance therapy in patients receiving moderately emetogenic chemotherapy. |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | ondansetron |
| Trade/Product Name: | zofran;zofran |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
